
Eating these common foods before bed could trigger sweet dreams or night terrors
Researchers say yes – and their findings could give late-night snackers something to think about.
Tore Nielsen, director of the University of Montreal's Dreams and Nightmares Laboratory, recently published his new findings in the journal Frontiers in Psychology on June 30.
The study suggests that not only does eating certain foods before bed influence how well you sleep, it also influences the nature of your dreams and whether they're pleasant, bizarre or unsettling.
Nielsen told Fox News Digital there were clear patterns in how certain food groups correlated with the quality and emotional tone of participants' dreams.
The culprits that worsened sleep included desserts, spicy foods and dairy foods.
Nearly 23% of the participants experienced negative dreams after consuming sweet foods, while 19.5% had nightmares after eating spicy fare.
Dairy choices, meanwhile, accounted for 15.7% of the bad dreams.
In terms of improving sleep, analysts found that those who ate "clean" before bedtime experienced better sleep at night.
Nearly 18% reported improved sleep after consuming fruit, while 13.4% reported better sleep after drinking herbal tea.
Some 12% of study participants also saw positive effects after consuming vegetables.
Nielsen's research also differentiated between disturbing dreams and bizarre dreams.
"People who develop nightmares might also take a look at the effects of medications, recreational drugs or alcohol that they're consuming."
"Of the participants who stated that they thought food affected their dreams, the top culprits blamed for disturbing dreams were desserts/sweets (31%), dairy (22%) and meat (16%)," Neilsen said.
"The top culprits blamed for bizarre dreams were again desserts/sweets (38%) and dairy (27%) — meat was a distant third (8%)."
The research also found that three significant habits contribute to poor sleep: eating dairy products despite being lactose intolerant, eating close to bedtime, and not following internal cues about when to stop eating.
"These results and the results from our previous study both also suggest that eating a healthier diet in general might reduce nightmares and the overall negativity of dreams," Nielsen observed.
While there's more research to be done, the Canadian psychologist said that the findings suggest that people with both severe nightmares and food allergies should be tested and change their diet accordingly.
"[If people test] positive for lactose intolerance or other food allergies, [they could] carefully dose the ingestion of the culprit foods to minimize their symptoms – especially at night," he said.
Nielsen also cautioned that food sensitivities and diet are "only two possible sources of nightmares."
"People who develop nightmares might also take a look at the effects of medications, recreational drugs or alcohol that they're consuming," the expert advised.
"Or sometimes withdrawal from substances such as cannabis can induce nightmares for some weeks afterward," he said.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Bloomberg
28 minutes ago
- Bloomberg
GSK's Blood Cancer Drug Blenrep Fails to Win FDA Panel Support
GSK Plc's blood cancer drug failed to secure the backing of a panel of US regulatory advisers, putting its approval in doubt. The US Food and Drug Administration 's Oncologic Drugs Advisory Committee voted that the risks from the drug, called Blenrep, outweighed its benefits. Panelists voted 5-to-3 against a combination of Blenrep and the generic cancer drug Velcade and 7-to-1 against the drug in tandem with Pomalyst, marketed by Bristol Myers Squibb Co.
Yahoo
an hour ago
- Yahoo
Medical waste found on P.E.I. property not believed to have any criminal aspect, RCMP say
The RCMP says there's no indication that a small pile of unsecured medical waste found on a rural property in eastern P.E.I. has any criminal aspect. In an email to CBC News Thursday, the RCMP said the provincial Department of Environment, Energy and Climate Action asked them to conduct a review of the waste and how it got to the vacant land near Murray River. "Our conclusion is that there is no information to suggest there is a criminal act or intent," the email reads. "RCMP will not be further involved in this, and we have no interest in the items recovered." Police say the property owners contracted a third-party service to clean up the waste. Earlier this month, CBC News reported on the discovery of what appeared to be vials of blood, testing strips and other medical waste.. The land is owned by Moonlight International Foundation, a non-profit with ties to the Buddhist community in the province. Photos obtained by CBC News via drone showed the materials in a loose pile on the ground. Some of the material had writing in Chinese characters. The Department of Environment, Energy and Climate Action confirmed staff had inspected the area on July 9, and said the amount of waste they found would fit into a small garbage bag. A spokesperson for the Moonlight International Foundation said in an email that the group had learned about the medical waste through correspondence with CBC News, calling it "truly a regrettable situation." Under the P.E.I. Environmental Protection Act's waste resource management regulations, no person can dispose of special waste, which includes medical waste, except at an appropriate landfill or composting facility that's approved to accept the material.
Yahoo
an hour ago
- Yahoo
Waud Capital Partners Forms New Partnership with Experienced Healthcare Executive Bill Mixon
Waud Capital Partners teams up with accomplished industry executive to acquire and build a healthcare supply chain solutions company CHICAGO, July 17, 2025 /PRNewswire/ -- Waud Capital Partners ("Waud Capital"), a growth-oriented middle-market private equity firm, announced today that it has formalized an executive partnership with Bill Mixon to pursue a platform investment in the medical device and supply chain services market. Targeted sub-sectors of focus will include but are not limited to home distribution, other value-add specialty distribution, outsourced provider equipment services, and chronic care and population health management offerings that deliver value to supply chain channel partners. Waud Capital anticipates investing over $100 million of equity capital to support the initiative. Mr. Mixon is an accomplished healthcare executive with more than 30 years of operating experience across the medical device and supply chain services continuum, with particular emphasis on specialty distribution and outsourced provider equipment services. He brings deep operational expertise with an extensive focus on enhancing clinical value and improving patient outcomes through the medical supply chain. Mr. Mixon has successfully scaled several private equity-backed and publicly traded organizations through repeatable organic growth strategies as well as strategic acquisitions. Most recently, Mr. Mixon served as Chief Executive Officer of Advanced Diabetes Supply, where he led the organization through a successful sale from its private equity sponsor to Cardinal Health. Advanced Diabetes Supply is a national diabetes care management platform distributing innovative therapies including continuous glucose monitors and other diabetes-related supplies. During his time at Advanced Diabetes Supply, Mr. Mixon drove transformational growth by professionalizing the organization through salesforce productivity enhancements, executing a shift in go-to-market initiatives, and delivering margin improvements through revenue cycle initiatives and other operational efficiencies. At time of sale to Cardinal Health, Advanced Diabetes Supply had grown to $1B in revenue and served nearly a half-million patients annually. Prior to Advanced Diabetes Supply, Mr. Mixon was the Chief Executive Officer of National Seating & Mobility, a provider of comprehensive mobility solutions to patients in the home. Under Mr. Mixon's leadership at National Seating & Mobility, the organization scaled through organic and inorganic methods and successfully transacted on several different occasions to multiple private equity sponsors. Mr. Mixon began his career with the U.S. Army before holding leadership positions at large organizations such as Baxter, Phillips, and Agiliti Health. "I'm excited to partner with Waud Capital to identify and help build what we hope will be an industry-leading business that supports and improves the overall healthcare supply chain," said Mr. Mixon. "Waud Capital's executive partnership approach, dedicated ecosystem resources, and deep investing experience across relevant areas make the firm a highly attractive partner. I believe this combination will enable us to capitalize on transformative growth opportunities, and I look forward to leveraging my past experiences to drive clinical value for medical professionals, manufacturers, payors and most importantly, patients." "We are thrilled to partner with Bill," said Mike Lehman, Principal at Waud Capital. "He is an exceptional executive who has created value and driven multiple successful outcomes throughout his career in a sector we find highly attractive. The healthcare supply chain markets are highly fragmented with significant opportunities for organizations to deliver value-add solutions and address substantial challenges for key stakeholders." This executive partnership builds upon Waud Capital's extensive experience investing across the broader healthcare supply chain services and home care markets. Notable investments include Mopec Group (supplier of pathology equipment, consumables and services), PromptCare (home infusion and durable medical equipment), Provider Network Holdings (specialty medication supply management), DS Medical (home medical supplies), and recent home care investments AltoCare (in-home senior care), and Concierge Home Care (skilled home healthcare). "The partnership with Bill is another example of Waud Capital's executive-first campaign approach and commitment to support accomplished executive leaders with the full ecosystem of resources to execute transformative growth strategies in large, growing markets," said Kyle Lattner, Partner at Waud Capital. "This is our second dedicated campaign in the medical device and supply chain services market in the last two years and we are thrilled about the prospects of what we can accomplish during our partnership with Bill." About Waud Capital PartnersBased in Chicago and founded by Reeve B. Waud, Waud Capital Partners is a growth-oriented private equity firm with over 30 years of investing experience. Waud Capital Partners seeks to partner with experienced management teams to build market-leading companies within two industries: healthcare and software & technology. Since its founding in 1993, Waud Capital has successfully completed more than 500 investments, including platform companies and follow-on opportunities. For additional information on Waud Capital, please visit Investment Professional Contacts:Kyle Lattner, Partner(312) 676-8404klattner@ Mike Lehman, Principal(312) 676-8446mlehman@ Business Development Contact:Phil Olson, Partner – Business Development(312) 676-8401polson@ Investor Relations Contact:Jessica Schmitt, Head of Investor Relations(312) 676-8400jschmitt@ View original content to download multimedia: SOURCE Waud Capital Partners